Medical News

RSS

Exercise reduces depression

Jumping on that treadmill or bike is not only good for one's health, but also can help significantly reduce depression, researchers at UT Southwestern Medical Center have found.

25 Jan 2005

Viacom and Kaiser launch year three of KNOW HIV/AIDS campaign

Viacom Inc. and the Henry J. Kaiser Family Foundation today announced the year-three launch of the Emmy and Peabody Award-winning public education initiative KNOW HIV/AIDS, which includes targeted public service announcements (PSAs), HIV-themed programming, and free print and online information resources.

24 Jan 2005

Vioxx could have caused 140000 excess cases of coronary heart disease in the USA since 1999

The arthritis drug Vioxx could have caused an estimated 88 000–140 000 excess cases of serious coronary heart disease in the USA since its launch in 1999, concludes a study published online by The Lancet.

24 Jan 2005

Drink-driving limit must be reduced to save lives

The British Medical Association in Wales is calling on the Government to reduce the blood alcohol concentration (BAC) level for driving from 80mg to 50mg per 100ml. In 2003 - the latest year when figures are available - there were 582 drink-related road traffic casualties in Wales, 6 of whom died - 2 of whom were pedestrians and 4 were passengers.

24 Jan 2005

Eating tuna or other broiled or baked fish lowers risk of stroke in the elderly

The consumption of tuna or other broiled or baked fish is associated with a lower risk of stroke in the elderly, while eating fried fish or fish sandwiches is linked to a higher risk, according to an article in the January 24 issue of Archives of Internal Medicine.

24 Jan 2005

Dietary fat quality may be more important than fat quantity in reducing risk of cardiovascular deaths in middle-aged men

The type of dietary fats consumed by middle-aged men, especially polyunsaturated fats and linoleic acids, may be more important than total fat intake in reducing the risk of cardiovascular deaths, according to a study in the January 24 issue of Archives of Internal Medicine.

24 Jan 2005

Vioxx withdrawal raises many questions concerning drug policy

Daniel H. Solomon, M.D., M.P.H., from Brigham and Women’s Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., “raises many questions concerning drug policy, scientific evidence, and treatment alternatives.

24 Jan 2005

Warfarin combined with NSAIDs or COX-2 inhibitors increased risk of upper gastrointentinal hemorrhage

Patients taking warfarin at the same time as selective COX-2 inhibitors or nonselective NSAIDs have an increased risk of hospitalization for upper gastrointestinal (GI) hemorrhage, according to Canadian researchers analyzing health care databases.

24 Jan 2005

Study of patients on COX-2 inhibitors does not show increased cardiovascular risk

An observational study of 6,250 patients enrolled in the Maryland Medicaid program found that COX-2 inhibitors did not increase the risk for cardiovascular events over nonnaproxen NSAIDs in a high-risk population.

24 Jan 2005

More studies on risks and benefits of COX-2 inhibitors

A group of studies published in the January 24 issue of Archives of Internal Medicine add to the growing body of medical literature about the cardiovascular risks that may be associated with the class of pain-relieving drugs known as COX-2 inhibitors.

24 Jan 2005

Living in a disadvantaged neighborhood may increase HIV risk

Living in a disadvantaged urban neighborhood can increase a male residents’ risk of contracting HIV, according to researchers at the Johns Hopkins Bloomberg School of Public Health. Their study related disadvantaged neighborhoods to stress and stress to increased injection drug use in male study participants.

24 Jan 2005

Breakthrough in identifying causes and treatment for degenerative neurological diseases

A new, high resolution x-ray scanning technique that can look inside a single brain tissue cell, is a major step forward in identifying the role of iron and other metals in degenerative neurological diseases such as Alzheimer’s and Parkinson’s.

24 Jan 2005

Phenoxodiol increases the effectiveness of Docetaxel by at least 100 times

The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.

24 Jan 2005

New blood tests to soon replace painful bone marrow biopsies for leukemia and lymphoma patients

Quest Diagnostics Incorporated announced today that The University of Texas M. D. Anderson Cancer Center in Houston has granted the company exclusive use of five proprietary blood testing methods, which, once available in the form of laboratory diagnostic tests, may eliminate the need for painful and expensive bone marrow and other tissue extractions.

24 Jan 2005